Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine.

[1]  M. Delaney.  The case for patient access to experimental therapy. , 1989, The Journal of infectious diseases.

[2]  J. Marx.  The trials of conducting AIDS drugs trials. , 1989, Science.

[3]  L. Lasagna,et al.  Obtaining Informed Consent: Form or Substance , 1969 .

[4]  N. Lynöe,et al.  Informed consent: study of quality of information given to participants in a clinical trial. , 1991, BMJ.

[5]  G. Morrow,et al.  A simple technique for increasing cancer patients' knowledge of informed consent to treatment , 1978, Cancer.

[6]  A Cuschieri,et al.  Factors affecting quality of informed consent. , 1993, BMJ.

[7]  M. Waldrop.  Space telescope delayed (again). , 1989, Science.

[8]  D. Byrne,et al.  How informed is signed consent? , 1988, British medical journal.

[9]  M. Ross,et al.  Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study. , 1994, AIDS care.

[10]  R. Flesch.  A new readability yardstick. , 1948, The Journal of applied psychology.

[11]  B. Cassileth,et al.  Informed consent -- why are its goals imperfectly realized? , 1980, The New England journal of medicine.

[12]  C. Spurr,et al.  Written informed consent in patients with breast cancer , 1979, Cancer.

[13]  M. Kirby.  Informed consent: what does it mean? , 1983, Journal of medical ethics.

[14]  E. Marshall.  Quick release of AIDS drugs. , 1989, Science.

[15]  G. Robinson,et al.  Informed consent: recall by patients tested postoperatively. , 1976, Connecticut medicine.